Charles Schwab Investment Management Inc. Has $267.15 Million Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Charles Schwab Investment Management Inc. grew its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 4.6% in the 4th quarter, HoldingsChannel.com reports. The fund owned 449,507 shares of the biotechnology company’s stock after purchasing an additional 19,818 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Axon Enterprise were worth $267,151,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. Groupama Asset Managment bought a new stake in Axon Enterprise in the third quarter worth $200,000. Massachusetts Financial Services Co. MA acquired a new stake in shares of Axon Enterprise in the third quarter worth about $120,553,000. Proficio Capital Partners LLC bought a new stake in shares of Axon Enterprise during the 4th quarter worth about $78,414,000. Westfield Capital Management Co. LP increased its holdings in shares of Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after acquiring an additional 127,769 shares during the last quarter. Finally, Assenagon Asset Management S.A. raised its stake in shares of Axon Enterprise by 328.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after acquiring an additional 111,405 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $534.96 on Thursday. The firm has a market capitalization of $40.79 billion, a price-to-earnings ratio of 138.23, a PEG ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99. The business has a fifty day simple moving average of $605.52 and a 200 day simple moving average of $527.52. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Insider Activity

In related news, President Joshua Isner sold 1,291 shares of Axon Enterprise stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total transaction of $829,377.13. Following the completion of the transaction, the president now directly owns 181,892 shares of the company’s stock, valued at $116,852,877.56. This trade represents a 0.70 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the sale, the director now owns 24,259 shares of the company’s stock, valued at $15,518,239.71. The trade was a 3.96 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 5,146 shares of company stock worth $3,262,847. 6.10% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Barclays set a $726.00 target price on shares of Axon Enterprise and gave the company an “overweight” rating in a research note on Thursday, February 27th. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Needham & Company LLC restated a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a report on Wednesday, February 26th. Finally, TD Cowen initiated coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective on the stock. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $587.38.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.